Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Phased Variant Enrichment for Enhanced Minimal Residual Disease Detection from Cell-Free DNA

David M. Kurtz, MD PhD, Joanne Soo, MD, Stefan Alig, MD, Lyron Co Ting Keh, Charles Macaulay, Michael C. Jin, BS, Florian Scherer, MD, Emily G. Hamilton, BS, Chih Long Liu, PhD, Binbin Chen, PhD, Alexander F. M. Craig, MPhil, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MD PhD

Blood (2019) 134 (Supplement_1): 552.

https://doi.org/10.1182/blood-2019-131267

Published: 2019

Journal Articles

Incidence, Diagnosis, and Outcome of Acquired Thrombotic Thrombocytopenic Purpura (aTTP): A Nationwide Survey By the Spanish Apheresis Group

Maria Cristina Pascual Izquierdo, PhD MD, Julio Del Rio-Garma, MD, Javier De La Rubia, Aurora Viejo, MD, Jesus Fernandez-Sojo, MD, Jesus Martin, MD, Xavier Solanich, MD, Faustino García-Candel, PhD MD, Luis Hernandez, MD, Marta Fernandez, MD, Ana Oliva, MD, Jose Maria Garcia-Gala, MD, Maria Eva Mingot-Castellano, PhD MD, Ines Gomez-Seguí, MD PhD, Rosa Goterris, MD, Michael Calviño, MD, María Luisa Antelo, MD PhD, Sol Sanchez, MD, Jose Antonio Moreno, MD, Cristina Amunarriz, MD, Jose Garcia-Arroba, MD, Carmen Fernandez, MD, Nieves Alonso, MD, Victoria Gonzalez, MD, Luisa Guerra, MD, M. Elena Moreno, MD, Moreno M. Dolores, MD, Gemma Moreno, MD, Melisa Daorta, MD, Esther Chica, MD, Rafael Del Orbe, MD PhD, Joan Cid, MD PhD, Margarita Berberana, MD, Carmen Ballester, MD, Sara Nistal Gil, MD, Julia Vidan, MD, Maite Calderon, MD, Consuelo Martinez Redondo, MD, Jose Carlos Hernandez, MD, Marina Gordillo, MD, Angel Salgado, Ramon Salinas, MD PhD

Blood (2019) 134 (Supplement_1): 4910.

https://doi.org/10.1182/blood-2019-123258

Published: 2019

Journal Articles

Detection of the Genomic Variants in the Paired De Novo-Relapsed Samples with Pan-Cancer Panel and Whole Exome-Seq in Adult B-Cell Acute Lymphoblastic Leukemia

Zheng Ge, MD PhD, Yuka Imamura Kawasawa, PhD, Yan Gu, MD, Qi Han, MD, Jie Zi, Chunhua Song, MD

Blood (2019) 134 (Supplement_1): 5206.

https://doi.org/10.1182/blood-2019-126750

Published: 2019

Journal Articles

New Insights into Mechanisms of Erythropoietin Receptor Mutations in Primary Familial and Congenital Polycythemia

Florence Pasquier, MD PhD, Caroline Marty, PhD, Frédérique Verdier, PhD, Sarah Grosjean, MBiol, Claude Préhu, MD, Stefan N. Constantinescu, MD PhD, Hana Raslova, PhD, Nicole Casadevall, MD, William Vainchenker, MD PhD, Christine Bellanné-Chantelot, PharmD, PhD, Isabelle Plo, PhD

Blood (2016) 128 (22): 631.

https://doi.org/10.1182/blood.V128.22.631.631

Published: 2016

Journal Articles

Phase I Study Of LY2784544, a JAK2 Selective Inhibitor, In Patients With Myelofibrosis (MF), Polycythemia Vera (PV), and Essential Thrombocythemia (ET)

Srdan Verstovsek, MD, PhD, Ruben A Mesa, MD, Mohamed E Salama, MD, Jennifer L K Giles, BSc, Celine Pitou, PharmD, Annamaria Hayden Zimmermann, MS, Gregory L Price, MPH, Richard A Walgreen, MD, Josef Prchal, MD

Blood (2013) 122 (21): 665.

https://doi.org/10.1182/blood.V122.21.665.665

Published: 2013

Journal Articles

Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations

Blood (2011) 117 (10): 2813–2816.

https://doi.org/10.1182/blood-2010-11-316810

Published: 2011

Includes: Supplemental data

Journal Articles

Final Results of the ANAHYDRET-Study: Non-Inferiority of Anagrelide Compared to Hydroxyurea in Newly Diagnosed WHO-Essential Thrombocythemia Patients

Heinz Gisslinger, Mirjana Gotic, Jerzy Holowiecki, Miroslav Penka, Juergen Thiele, Hans Michael Kvasnicka, Robert Kralovics, Petro E. Petrides

Blood (2008) 112 (11): 661.

https://doi.org/10.1182/blood.V112.11.661.661

Published: 2008

Journal Articles

The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia

Luciana Teofili, Fiorina Giona, Maurizio Martini, Tonia Cenci, Francesco Guidi, Lorenza Torti, Giovanna Palumbo, Angela Amendola, Giuseppe Leone, Robin Foà, Luigi M. Larocca

Blood (2007) 110 (9): 3384–3386.

https://doi.org/10.1182/blood-2007-06-094276

Published: 2007

NARROW

Phased Variant Enrichment for Enhanced Minimal Residual Disease Detection from Cell-Free DNA

Incidence, Diagnosis, and Outcome of Acquired Thrombotic Thrombocytopenic Purpura (aTTP): A Nationwide Survey By the Spanish Apheresis Group

Detection of the Genomic Variants in the Paired De Novo-Relapsed Samples with Pan-Cancer Panel and Whole Exome-Seq in Adult B-Cell Acute Lymphoblastic Leukemia

New Insights into Mechanisms of Erythropoietin Receptor Mutations in Primary Familial and Congenital Polycythemia

Phase I Study Of LY2784544, a JAK2 Selective Inhibitor, In Patients With Myelofibrosis (MF), Polycythemia Vera (PV), and Essential Thrombocythemia (ET)

Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations

Final Results of the ANAHYDRET-Study: Non-Inferiority of Anagrelide Compared to Hydroxyurea in Newly Diagnosed WHO-Essential Thrombocythemia Patients

The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only